Target intelligence / Profile preview

Lysophosphatidylglycerol phospholipase D (LpgD)

Target
LpgD
Molecular classification
Enzyme, Phospholipase D, Glycerophosphodiester phosphodiesterase (GDPD)
01

Overview

Lysophosphatidylglycerol phospholipase D (LpgD) is a recently characterized enzyme in Staphylococcus aureus that plays a critical role in maintaining membrane homeostasis by managing the levels of lysophosphatidylglycerol (LPG). It functions as a cation-dependent phosphodiesterase that converts 1-acyl-LPG into lysophosphatidic acid (LPA), which is then recycled back into the phosphatidylglycerol (PG) biosynthetic pathway. By preventing the accumulation of LPG, which can destabilize the bacterial membrane at high concentrations, LpgD ensures the integrity and functionality of the cell envelope during infection. Although no clinical drugs currently target LpgD, its essential role in bacterial lipid metabolism and its distinct structural features make it a promising target for the development of novel anti-staphylococcal agents. Research indicates that LpgD belongs to the glycerophosphodiester phosphodiesterase (GDPD) family and utilizes a two-step catalytic mechanism involving a cyclic-LPA intermediate. Inhibiting this enzyme could potentially sensitize S. aureus to host immune defenses or existing antibiotics by compromising its membrane stability.

Other names
LPG phospholipase DLpgD enzymeSAUSA300_1020Glycerophosphodiester phosphodiesterase LpgD
02

Mechanism of action

Inhibition of LpgD activity disrupts the recycling of lysophosphatidylglycerol (LPG) into the phosphatidylglycerol (PG) biosynthetic pathway, leading to membrane destabilization and impaired bacterial survival.

03

Biological functions

Lipid metabolismMembrane homeostasisPhospholipid recyclingCell wall biosynthesis support
04

Disease associations

Infection (Staphylococcus aureus)Bacterial pathogenesisAntimicrobial resistance
05

Safety considerations

Potential off-target effects on human glycerophosphodiester phosphodiesterases (GDEs)Bacterial adaptation and compensatory lipid pathways
06

Biomarkers

Lysophosphatidylglycerol (LPG) levelsLysophosphatidic acid (LPA) levelsMembrane lipid composition

Beyond the preview

Go deeper on Lysophosphatidylglycerol phospholipase D (LpgD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysophosphatidylglycerol phospholipase D (LpgD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call